PH12898A - A composition for the treatment of calcific tumors - Google Patents
A composition for the treatment of calcific tumorsInfo
- Publication number
- PH12898A PH12898A PH15822A PH15822A PH12898A PH 12898 A PH12898 A PH 12898A PH 15822 A PH15822 A PH 15822A PH 15822 A PH15822 A PH 15822A PH 12898 A PH12898 A PH 12898A
- Authority
- PH
- Philippines
- Prior art keywords
- treatment
- composition
- calcific tumors
- calcific
- tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3839—Polyphosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36297173A | 1973-05-23 | 1973-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12898A true PH12898A (en) | 1979-10-04 |
Family
ID=23428261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH15822A PH12898A (en) | 1973-05-23 | 1974-05-10 | A composition for the treatment of calcific tumors |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE815397A (xx) |
| DE (1) | DE2424453C3 (xx) |
| FR (1) | FR2230374A1 (xx) |
| NL (1) | NL7406952A (xx) |
| PH (1) | PH12898A (xx) |
| ZA (1) | ZA743159B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5871000A (en) | 1999-06-11 | 2001-01-02 | Paul G. Abrams | High dose radionuclide complexes for bone marrow suppression |
| US7094885B2 (en) | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
| US6547816B1 (en) | 1999-07-12 | 2003-04-15 | Civatech Corporation | Formable integral source material for medical devices |
| CA2372786C (en) * | 2000-02-18 | 2010-03-30 | Civatech Corporation | Formable integral source material for medical and industrial devices |
| US7686756B2 (en) | 2006-08-29 | 2010-03-30 | Ciratech Oncology | Brachytherapy devices and related methods and computer program products |
-
1974
- 1974-05-10 PH PH15822A patent/PH12898A/en unknown
- 1974-05-17 ZA ZA00743159A patent/ZA743159B/xx unknown
- 1974-05-20 DE DE2424453A patent/DE2424453C3/de not_active Expired
- 1974-05-22 FR FR7417965A patent/FR2230374A1/fr active Granted
- 1974-05-22 BE BE144624A patent/BE815397A/xx unknown
- 1974-05-22 NL NL7406952A patent/NL7406952A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7406952A (xx) | 1974-11-26 |
| BE815397A (fr) | 1974-11-22 |
| DE2424453C3 (de) | 1981-02-26 |
| FR2230374B1 (xx) | 1978-07-21 |
| FR2230374A1 (en) | 1974-12-20 |
| ZA743159B (en) | 1975-05-28 |
| DE2424453B2 (de) | 1980-06-12 |
| DE2424453A1 (de) | 1974-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL44620A (en) | 5-oxa- -aryl-prostaglandin f1 compounds | |
| ZA722506B (en) | Tetrachlorophthalide compounds | |
| ZA732683B (en) | Therapeutic agent | |
| ZM16774A1 (en) | Compounds | |
| JPS52151636A (en) | Composition for sensitizing treatment | |
| AU7439274A (en) | Catheters | |
| AU7031674A (en) | Novel compounds | |
| AU6977274A (en) | Compounds | |
| ZA743765B (en) | New therapeutical compositions | |
| PH12898A (en) | A composition for the treatment of calcific tumors | |
| GB1407933A (en) | Sulphenylation of n-arylheterocyclic compounds | |
| HK62778A (en) | Pathalocyanine compounds | |
| IL45739A (en) | Process for the priparation of 6-deoxytetracyclines | |
| AU7040074A (en) | Compounds | |
| AU4775472A (en) | New polyepoxide-polysiloxane compounds | |
| CA1028246A (en) | Compositions for the treatment of calcific tumors | |
| ZA744888B (en) | Therapeutical composition for the treatment of mycobacterioses | |
| ZA744584B (en) | Novel n-hydroxy-amidine compounds | |
| YU151174A (en) | Process for the dehalogenization of 11-a-halo-methylene-tetracycline | |
| ZA75607B (en) | Pharmaceutical composition for the treatment of cancer | |
| AU7528074A (en) | Compounds | |
| AU6677774A (en) | Triphenyl-tin compounds | |
| AU6436474A (en) | Compounds | |
| GB1408729A (en) | Sulphilimine compounds | |
| ZA747894B (en) | Process for the preparation of alkylsulfonated compounds |